NCT01461746View on ClinicalTrials.gov

Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Endometrial Cancer
Interventions
DRUG

Docetaxel

Docetaxel 70mg/m2BSA, q 3 weeks, 3 cycles

DRUG

Cisplatin

Cisplatin 60mg/m2BSA, q 3 weeks, 3 cycles

RADIATION

Radiation therapy

Pelvic radiation therapy (Extended filed radiation therapy and addition of brachytherapy is allowed)

Trial Locations (1)

138-736

RECRUITING

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Boryung Pharmaceutical Co., Ltd

INDUSTRY

lead

Asan Medical Center

OTHER

NCT01461746 - Efficacy Study of Chemotherapy Followed by Radiation Therapy to Treat Endometrial Cancer | Biotech Hunter | Biotech Hunter